Vistin Pharma ASA (OSL:VISTN)
19.35
+0.15 (0.78%)
At close: Nov 13, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 858.07 million as of November 13, 2026. It is the 25,670th most valuable company in the world and the 174th biggest in Norway. Its market cap has decreased by 5.61% in one year.
Market Cap
858.07M
Enterprise Value
836.05M
Revenue
431.55M
Global Rank
Country Rank
#174 Norway
PE Ratio
13.70
ChartMarket Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 858.07M, an increase of 166.20%. That is a compound annual growth rate of 8.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 858.07M | -6.97% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.73B |
| Circio Holding ASA | 2.73B |
| Nordhealth AS | 2.07B |
| Thor Medical ASA | 1.72B |
| Photocure ASA | 1.16B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.10B |
| Omda AS | 943.35M |